Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Lung Neoplasms 6Colorectal Neoplasms 6Stomach Neoplasms 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Hematologic Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Rectal Neoplasms 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3COVID-19 3Uterine Cervical Neoplasms 2Smoking 2Sarcoma 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma 2Head and Neck Neoplasms 2Head and Neck Carcinoma 2Glioblastoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Xerostomia 1Urologic Neoplasms 1Urologic Diseases 1

Interventions

balstilimab 2tremelimumab 1spartalizumab 1pembrolizumab 1lenvatinib 1Standard of Care 1Pemetrexed 1Nivolumab 1Ipilimumab 1Carboplatin 1Axitinib 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Diabetes Mellitus, Insulin-Dependent, 12 × Standard of Care × Clear all
NCT05608044 2025-09-04

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Agenus Inc.

Phase 2 Active not recruiting
234 enrolled
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡